Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder

NCT01054222 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Bladder, Overactive

Interventions

DRUG: Fesoterodine
DRUG: Fesoterodine

Sponsor

Pfizer